ClinicalTrials.govpublic full text
REGROUP: Renohemodynamic Effects empaGliflozin in vaRiOUs Populations
diabetes mellitus, type 2, chronic kidney diseases, sodium glucose cotransporter 2, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 888223
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.